Local Phone: 0845 260 2602
Virtue Drinks, a pioneering clean-label beverage company, has successfully closed a £2m funding round as it gears up to...
Read MoreA groundbreaking new treatment for asthma and chronic obstructive pulmonary disease (COPD) could revolutionise how these life-threatening conditions are...
Read MoreIn a significant milestone for autoimmune disease research, argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative...
Read MoreEdinburgh-based biotech company Cytomos has announced a significant milestone, raising $5m (approximately £3.98m) in an oversubscribed funding round to...
Read MoreCoca-Cola Europacific Partners (CCEP) is reinforcing its commitment to innovation and sustainability with a significant £42.3m investment in a...
Read MoreTeva Pharmaceuticals and Immunai, a leader in artificial intelligence (AI)-driven immune system mapping, have announced a groundbreaking multi-year partnership...
Read More
